Teva Pharmaceutical Industries Limited · TASE:TEVA

Teva Pharmaceutical Industries — Credit Suisse 2011 Healthcare Conference

7 slides from Teva Pharmaceutical Industries's conference presentation, Nov 10, 2011

  1. Slide 1: Credit Suisse 2011 Healthcare Conference

    Eyal Desheh, Chief Financial Officer Credit Suisse 2011 Healthcare Conference November 10, 2011 Investor Relations 1

  2. Slide 2: Forward Looking Statement

    Forward Looking Statement TODAY’S PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS, WHICH EXPRESS THE CURRENT BELIEFS AND EXPECTATIONS OF MANAGEMENT. SUCH STATEMENTS INVOLVE A NUMBER OF KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES THAT COULD CAUSE OUR FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS TO DIFF

  3. Slide 3: Q3 2011 highlights

    Q3 2011 highlights Strong growth (especially organic) in Europe, EMIA, LATAM and Canada Europe: another strong quarter with 9% organic growth, a demonstration of Teva’s diversity  5 Major M j markets k t with ith organic i growth th off 14%  Germany - in September, became market leader in both val

  4. Slide 4: Q3 2011 results

    Q3 2011 results Q3/11* Q3/10* Change g Sales 4,344 4,250 +2% $m Operating income 1,316 1,439 -9% $m $ Net income 1,111 1,182 -6% $m EPS 1.25 1.30 -4% $ T Tough h y/y / comparison i * Net income, operating income and EPS are non-GAAP results Investor Relations 4

  5. Slide 5: Q3 2011 results – significant QoQ improvement

    Q3 2011 results – significant QoQ improvement Q3/11* Q2/11* Change g Sales 4,344 4,212 +3% $m Operating income 1,316 1,091 +20% $m $ Net income 1,111 984 +13% $m EPS 1.25 1.10 +14% $ * Net income, operating income and EPS are non-GAAP results Investor Relations 5

  6. Slide 6: Executing on long-term strategic initiatives

    Executing on long-term strategic innitiatives Long-term GENERICS Strategic Plan: ratiopharm: GX #1 in Europe Taiyo: leadership in Japan Infarmasa: expansion p in LA DIVERSIFY TEVA Progress BRANDED Cephalon: expansion/diversification Theramex: global expansion women’s health OTC JV with P&G: leverage

  7. Slide 7: Thank you

    Thank y you Investor Relations 7

Teva Pharmaceutical Industries — Credit Suisse 2011 Healthcare Conference on 6ix